Gevo (GEVO) director awarded 80,893 stock options at $1.80
Gevo, Inc. director William H. Baum was granted 80,893 stock options with an exercise price of $1.80 per share, expiring on May 26, 2036. These options will vest at the earlier of the next annual shareholder meeting or the first anniversary of the grant, provided he remains in continuous service. This grant is part of his compensation and not an open-market transaction.
FLXR ETF Analysis: Dividends, Returns NYSE:FLXR
This article provides an analysis of the TCW Flexible Income ETF (FLXR), covering its key statistics, investment strategy, asset allocation, and dividend information. FLXR is an actively managed ETF that invests globally in bonds and debt securities, with a significant portion in securitized and corporate bonds. The fund converted from a mutual fund structure in June 2024 and currently boasts a dividend yield of 5.70%.
Republic Services adjusting pickup times in June due to extreme heat
Republic Services announced changes to its trash and recycling pickup times in Southern Nevada, starting June 8. Collections will begin at 5:30 a.m. daily to ensure driver safety and service levels during extreme summer heat. The company anticipates these adjusted times will remain in effect through September, with potential changes if high temperatures do not persist.
ResMed Inc (RMD) Stock Down 6.3% -- Now Undervalued? GF Score: 9
ResMed Inc (RMD) shares dropped 6.3%, bringing its price to $190.57, which is 29.6% below its GF Value™ of $270.57, indicating it is undervalued. The company has a strong GF Score™ of 94/100, driven by excellent profitability and growth ratings, but insider selling of $4.9 million potentially signals caution for investors. RMD's current P/E ratio is also significantly lower than its historical median, further suggesting an undervaluation.
Guardant Health director sells $130,060 of common stock
A director at Guardant Health, Manuel Hidalgo Medina, sold 1,000 shares of common stock for $130,060 on May 28, 2026. This transaction occurred while the company's stock is near its 52-week high after a significant 246% return over the past year. Despite recent positive developments like FDA approval for its Guardant360 Liquid CDx test and several analyst price target increases, Guardant Health remains unprofitable, and analysts do not expect profitability this year.
Huntington Ingalls Industries Inc (HII) Shares Fall 4.0% -- What GF Score of 88 Tells Investors
Shares of Huntington Ingalls Industries Inc (HII) fell 4.0% to $308.17. Despite a strong GF Score of 88/100, indicating high profitability and growth, the stock is considered 7.2% overvalued according to GuruFocus' GF Value estimate of $287.51. Adding to this concern, insiders have sold $7.4 million worth of HII stock recently with no buying activity, suggesting a potential lack of confidence among those closest to the company.
Chubb Ltd. stock outperforms competitors despite losses on the day
Chubb Ltd. (CB) stock fell 1.42% to $311.73 on Friday, marking its fifth consecutive day of losses. Despite this decline, the stock underperformed the broader market, as the S&P 500 Index rose 0.22% and the Dow Jones Industrial Average increased by 0.72% on the same day.
Super Micro Stock Rally Misses the Point From Dell Earnings
Shares of Super Micro Computer surged following strong earnings from Dell Technologies, an AI server peer. However, the article suggests that Dell's success, particularly in server competition, could actually pose a risk for Super Micro shareholders.
TJX Companies Files For Debt Shelf Offering, Size Not Disclosed
TJX Companies has filed for a debt shelf offering, though the specific size of the offering was not disclosed. This information was reported by Refinitiv and is a brief financial announcement regarding the company's intent to potentially issue debt in the future.
PulteGroup Inc. stock (US7458671010): shares steady as buyback and analyst consensus stay in focus
PulteGroup Inc. shares remained steady on the NYSE, trading at USD 118.01, as investors considered a new $1.50 billion share repurchase plan approved on April 23, 2026. The company also holds a "Moderate Buy" consensus from MarketBeat with an average target price of USD 140.71, exceeding the current share price. PulteGroup's business model focuses on building and selling single-family homes and developing master-planned communities across the United States.


